Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer
Yazar
GEDİKBAŞI, Asuman
Kumbasar, Abdulbaki
Hursitoglu, Mehmet
Acarer, Didem
Harmankaya, Ozlem
OKUTURLAR, Yıldız
Gunaldi, Meral
Kocoglu, Hakan
Üst veri
Tüm öğe kaydını gösterÖzet
Aim: The aims of this study are to evaluate the serum levels of paraoxonase (PON) and arylesterase (ARE) in breast cancer (BC) patients; to determine their relationship with chemotherapy requirements in BC; and to find a cut-off value to assess subjects with a higher risk of BC.
Koleksiyonlar
- Makale [92796]